U.S. markets open in 1 hour 47 minutes
  • S&P Futures

    3,857.25
    +9.00 (+0.23%)
     
  • Dow Futures

    31,114.00
    +101.00 (+0.33%)
     
  • Nasdaq Futures

    11,920.25
    +40.00 (+0.34%)
     
  • Russell 2000 Futures

    1,732.80
    +4.20 (+0.24%)
     
  • Crude Oil

    99.61
    +1.08 (+1.10%)
     
  • Gold

    1,741.50
    +5.00 (+0.29%)
     
  • Silver

    19.33
    +0.17 (+0.89%)
     
  • EUR/USD

    1.0197
    +0.0012 (+0.12%)
     
  • 10-Yr Bond

    2.9130
    0.0000 (0.00%)
     
  • Vix

    26.67
    -0.87 (-3.16%)
     
  • GBP/USD

    1.1977
    +0.0055 (+0.46%)
     
  • USD/JPY

    135.8160
    -0.0990 (-0.07%)
     
  • BTC-USD

    20,450.63
    +345.47 (+1.72%)
     
  • CMC Crypto 200

    445.23
    +9.70 (+2.23%)
     
  • FTSE 100

    7,178.86
    +71.09 (+1.00%)
     
  • Nikkei 225

    26,490.53
    +382.88 (+1.47%)
     

Thermo Fisher Scientific Declares Quarterly Dividend

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

WALTHAM, Mass., May 19, 2022--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on May 18, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on July 15, 2022, to shareholders of record as of June 15, 2022.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220519005619/en/

Contacts

Media Contact Information:
Ron O’Brien
781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com

Investor Contact Information:
Rafael Tejada
781-622-1356
rafael.tejada@thermofisher.com